# Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain

> **NCT01466764** · NA · TERMINATED · sponsor: **Stanford University** · enrollment: 13 (actual)

## Conditions studied

- Pain
- Inflammation

## Interventions

- **DRUG:** Anakinra
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT01466764
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Due to inability to demonstrate benefit in this patient population.
- **Last updated:** 2017-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466764, "Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01466764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*